Use of an argatroban-based purge solution in a percutaneous ventricular assist device.

Laliberte, Benjamin; Reed, Brent N

Laliberte, Benjamin; Reed, Brent N.

Affiliation

Laliberte B; Pharmacy Department, Massachusetts General Hospital, Boston, MA.
Reed BN; Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD. breed@rx.umaryland.edu.

Am J Health Syst Pharm ; 74(9): e163-e169, 2017 May 01.

Article in En | MEDLINE | ID: mdl-28438820

Subject(s)

Anticoagulants/administration & dosage; Blood Coagulation/drug effects; Heart-Assist Devices/adverse effects; Pipecolic Acids/administration & dosage; Thrombocytopenia/prevention & control; Aged; Anticoagulants/adverse effects; Arginine/analogs & derivatives; Drug Substitution; Female; Heparin/adverse effects; Humans; Shock, Cardiogenic/etiology; Shock, Cardiogenic/surgery; Sulfonamides; Takotsubo Cardiomyopathy/complications; Thrombocytopenia/chemically induced; Treatment Outcome

Key words

anticoagulants; argatroban; cardiogenic shock; heart failure; heart-assist devices; thrombocytopenia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pipecolic Acids / Thrombocytopenia / Blood Coagulation / Heart-Assist Devices / Anticoagulants Type of study: Etiology_studies Language: En Journal: Am J Health Syst Pharm Year: 2017 Type: Article Affiliation country: Morocco

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google